Harvard spinout Nabla Bio lands $11M to bring AI technology to antibody design


Nabla Bio emerged from the lab of famed Harvard scientists George Church last year, and its antibody discovery technology has already led to five partnerships with pharma and biotech companies. The startup just closed an $11 million seed financing that will support further development of its technology.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.